Monogenic disorders of obesity and body fat distribution

Journal of Lipid Research

Volumn 40, Issue 10, 1999, Pages 1735-1746

  Chen, Dali ^a   Garg, Abhimanyu ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Congenital generalized lipodystrophy; Familial partial lipodystrophy; Leptin; Leptin receptor; Melanocortin receptors; Melanocyte stimulating hormone

Indexed keywords

FURIN; LEPTIN; LEPTIN RECEPTOR; MELANOCORTIN RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PROOPIOMELANOCORTIN;

BODY FAT; DOMINANT INHERITANCE; GENE MUTATION; HUMAN; HYPOPHYSIS DISEASE; HYPOTHALAMUS DISEASE; LIPODYSTROPHY; MONOGENIC DISORDER; OBESITY; PHENOTYPE; PRIORITY JOURNAL; RECESSIVE INHERITANCE; REVIEW;

EID: 0032829033     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (132)

1. Foster, D. W. 1998. The lipodystrophies and other rare disorders of adipose tissue. In Harrison's Principles of Internal Medicine. A. S. Fauci, E. Braunwald, K. J. Isselbacher, et al., editors. McGraw-Hill, New York. 2209-2214.
2. Perusse, L., Y. C. Chagnon, J. Weisnagel, and C. Bouchard. 1999. The human obesity gene map: the 1998 update. Obes. Res. 7: 111-129.
3. Bultman, S. J., E. J. Michaud, and R. P. Woychik. 1992. Molecular characterization of the mouse agouti locus. Cell. 71: 1195-1204.
4. Yen, T. T., A. M. Gill, L. G. Frigeri, G. S. Barsh, and G. L. Wolff. 1994. Obesity, diabetes, and neoplasia in yellow A(vy)/-mice: ectopic expression of the agouti gene. FASEB J. 8: 479-488.
5. Michaud, E. J., S. J. Bultman, L. J. Stubbs, and R. P. Woychik. 1993. The embryonic lethality of homozygous lethal yellow mice (Ay/Ay) is associated with the disruption of a novel RNA-binding protein. Genes Dev. 7: 1203-1213.
6. Michaud, E. J., M. J. van Vugt, S. J. Bultman, H. O. Sweet, M. T. Davisson, and R. P. Woychik. 1994. Differential expression of a new dominant agouti allele (Aiapy) is correlated with methylation state and is influenced by parental lineage. Genes Dev. 8: 1463-1472.
7. Lu, D., D. Willard, I. R. Patel, S. Kadwell, L. Overton, T. Kost, M. Luther, W. Chen, R. P. Woychik, W. O. Wilkison, and R. D. Cone. 1994. Agouti protein is an antagonist of the melanocyte-stimulating-hormone receptor. Nature. 371: 799-802.
8. Hauschka, T. S., B. B. Jacobs, and B. A. Holdridge. 1968. Recessive yellow and its interaction with belted in the mouse. J. Hered. 59:339-341.
9. Wolff, G. L., D. B. Galbraith, O. E. Domon, and J. M. Row. 1978. Phaeomelanin synthesis and obesity in mice. Interaction of the viable yellow (Avy) and sombre (eso) mutations. J. Hered. 69: 295-298.
10. Cone, R. D., and K. G. Mountjoy. 1993. Molecular genetics of the ACTH and melanocyte-stimulating hormone receptors. Trends Endocrinol. Metab. 4: 242-247.
11. Huszar, D., C. A. Lynch, V. Fairchild-Huntress, J. H. Dunmore, Q. Fang, L. R. Berkemeier, W. Gu, R. A. Kesterson, B. A. Boston, R. D. Cone, F. J. Smith, L. A. Campfield, P. Burn, and F. Lee. 1997. Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell. 88: 131-141.
12. O'Donohue, T. L., G. E. Handelmann, T. Chaconas, R. L. Miller, and D. M. Jacobowitz. 1981. Evidence that N-acetylation regulates the behavioral activity of alpha-MSH in the rat and human central nervous system. Peptides. 2: 333-344.
13. Mountjoy, K. G., D. H. Willard, and W. O. Wilkison. 1999. Agouti antagonism of melanocortin-4 receptor: greater effect with desacetyl-alpha-melanocyte-stimulating hormone (MSH) than with alpha-MSH. Endocrinology. 140: 2167-2172.
14. Graham. M., J. R. Shutter, U. Sarmiento, I. Sarosi, and K. L. Stark. 1997. Overexpression of Agrt leads to obesity in transgenic mice. Nat. Genet. 17:273-274.
15. Ollmann, M. M., B. D. Wilson, Y. K. Yang, J. A. Kerns, Y. Chen, I. Gantz, and G. S. Barsh. 1997. Antagonism of central melanocortin receptors in vitro and in vivo by agouti-related protein. Science. 278: 135-138.
16. Roselli-Rehfuss, L., K. G. Mountjoy, L. S. Robbins, M. T. Mortrud, M. J. Low, J. B. Tatro, M. L. Entwistle, R. B. Simerly, and R. D. Cone. 1993. Identification of a receptor for gamma melanotropin and other proopiomelanocortin peptides in the hypothalamus and limbic system, Proc. Natl. Acad. Sci. USA. 90: 8856-8860.
17. Miller, K. A., T. M. Gunn, M. M. Carrasquillo, M. L. Lamoreux, D. B. Galbraith, and G. S. Barsh. 1997. Genetic studies of the mouse mutations mahogany and mahoganoid. Genetics. 146: 1407-1415.
18. Dinulescu, D. M., W. Fan, B. A. Boston, K. McCall, M. L. Lamoreux, K. J. Moore, J. Montagno, and R. D. Cone. 1998. Mahogany (mg) stimulates feeding and increases basal metabolic rate independent of its suppression of agouti. Proc. Natl. Acad. Sci. USA. 95: 12707-12712.
19. Nagle, D. L., S. H. McGrail, J. Vitale, E. A. Woolf, B. J. Dussault, Jr., L. DiRocco, L. Holmgren, J. Montagno, P. Bork, D. Huszar, V. Fairchild-Huntress, P. Ge, J. Keilty, C. Ebeling, L. Baldini, J. Gilchrist, P. Burn, G. A. Carlson, and K. J. Moore. 1999. The mahogany protein is a receptor involved in suppression of obesity. Nature. 398: 148-152.
20. Gunn, T. M., K. A. Miller, L. He, R. W. Hyman, R. W. Davis, A. Azarani, S. F. Schlossman, J. S. Duke-Cohan, and G. S. Barsh. 1999. The mouse mahogany locus encodes a transmembrane form of human attractin. Nature. 398: 152-156.
21. Coleman, D. L., and E. M. Eicher. 1990. Fat (fat) and tubby (tub): two autosomal recessive mutations causing obesity syndromes in the mouse. J. Hered. 81: 424-427.
22. Kleyn, P. W., W. Fan, S. G. Kovats, J. J. Lee, J. C. Pulido, Y. Wu, L. R. Berkemeier, D. J. Misumi, L. Holmgren, O. Charlat, E. A. Woolf, O. Tayber, T. Brody, P. Shu, F. Hawkins, B. Kennedy, L. Baldini, C. Ebeling, G. D. Alperin, J. Deeds, N. D. Lakey, J. Culpepper, H. Chen, M. A. Glucksmann-Kuis, G. A. Carlson, G. M. Duyk, and K. J. Moore. 1996. Identification and characterisation of the mouse obesity gene tubby: a member of a novel gene family. Cell. 85: 281-290.
23. North, M. A., J. K. Naggert, Y. Yan, K. Noben-Trauth, and P. M. Nishina. 1997. Molecular characterization of TUB, TULP1, and TULP2, members of the novel tubby gene family and their possible relation to ocular diseases. Proc. Natl. Acad. Sci. USA. 94: 3128-3133.
24. Nishina, P. M., M. A. North, A. Ikeda, Y. Yan, and J. K. Naggert. 1998. Molecular characterization of a novel tubby gene family member, TULP3, in mouse and humans. Genomics. 54: 215-220.
25. Hagstrom, S. A., M. A. North, P. L. Nishina, E. L. Berson, and T. P. Dryja. 1998. Recessive mutations in the gene encoding the tubby-like protein TULP1 in patients with retinitis pigmentosa. Nat. Genet. 18: 174-176.
26. Banerjee, P., P. W. Kleyn, J. A. Knowles, C. A. Lewis, B. M. Ross, E. Parano, S. G. Kovats, J. J. Lee, G. K. Penchaszadeh, J. Ott, S. G. Jacobson, and T. C. Gilliam. 1998. TULP1 mutation in two extended Dominican kindreds with autosomal recessive retinitis pigmentosa. Nat. Genet. 18: 177-179.
27. Naggert, J. K., L. D. Fricker, O. Varlamov, P. M. Nishina, Y. Rouille, D. F. Steiner, R. J. Carroll, B. J. Paigen, and E. H. Leiter. 1995. Hyperproinsulinaemia in obese fat/fat mice associated with a carboxypeptidase E mutation which reduces enzyme activity. Nat. Genet. 10: 135-142.
28. Cool, D. R., E. Normant, F. Shen, H. C. Chen, L. Pannell, Y. Zhang, and Y. P. Loh. 1997. Carboxypeptidase E is a regulated secretory pathway sorting receptor: genetic obliteration leads to endocrine disorders in Cpe(fat) mice. Cell. 88: 73-83.
29. Cool, D. R., and Y. P. Loh. 1998. Carboxypeptidase E is a sorting receptor for prohormones: binding and kinetic studies. Mol. Cell. Endocrinol. 139:7-13.
30. Coleman, D. L., and D. L. Burkart. 1977. Plasma corticosterone concentrations in diabetic (db) mice. Diabetologia. 13: 25-26.
31. Coleman, D. L. 1978. Obese and diabetes: two mutant genes causing diabetes-obesity syndromes in mice. Diabetologia. 14: 141-148.
32. Bray, G. A., and D. A. York. 1979. Hypothalamic and genetic obesity in experimental animals: an autonomie and endocrine hypothesis. Physiol. Rev. 59: 719-809.
33. Zhang, Y., R. Proenca, M. Maffei, M. Barone, L. Leopold, and J. M. Friedman. 1994. Positional cloning of the mouse obese gene and its human homologue. Nature. 372: 425-432.
34. Chung, W. K., K. Belfi, M. Chua, J. Wiley, R. Mackintosh, M. Nicolson, C. N. Boozer, and R. L. Leibel. 1998. Heterozygosity for Lep(ob) or Lep(rdb) affects body composition and leptin homeostasis in adult mice. Am. J. Physiol. 274: R985-990.
35. Pelleymounter, M. A., M. J. Cullen, M. B. Baker, R. Hecht, D. Winters, T. Boone, and F. Collins. 1995. Effects of the obese gene product on body weight regulation in ob/ob mice. Science. 269: 540-543.
36. Halaas, J. L., K. S. Gajiwala, M. Maffei, S. L. Cohen, B. T. Chait, D. Rabinowitz, R. L. Lallone, S. K. Burley, and J. M. Friedman. 1995. Weight-reducing effects of the plasma protein encoded by the obese gene. Science. 269: 543-546.
37. Campfield, L. A., F. J. Smith, Y. Guisez, R. Devos, and P. Burn. 1995. Recombinant mouse OB protein: evidence for a peripheral signal linking adiposity and central neural networks. Science. 269: 546-549.
38. Chehab, F. F., M. E. Lim, and R. Lu. 1996. Correction of the sterility defect in homozygous obese female mice by treatment with the human recombinant leptin. Nat. Genet. 12: 318-320.
39. Flier, J. S. 1998. Clinical review 94: What's in a name? In search of leptin's physiologic role. J. Clin. Endocrinol. Metab. 83: 1407-1413.
40. Prolo, P., M. L. Wong, and J. Licinio. 1998. Leptin. Int. J. Biochem. Cell Biol. 30: 1285-1290.
41. Masuzaki, H., Y. Ogawa, N. Sagawa, K. Hosoda, T. Matsumoto, H. Mise, H. Nishimura, Y. Yoshimasa, I. Tanaka, T. Mori, and K. Nakao. 1997. Nonadipose tissue production of leptin: leptin as a novel placenta-derived hormone in humans. Nat. Med. 3: 1029-1033.
42. Bado, A., S. Levasseur, S. Attoub, S. Kermorgant, J. P. Laigneau, M. N. Bortoluzzi, L. Moizo, T. Lehy, M. Guerre-Millo, Y. Le Marchand-Brustel, and M. J. Lewin. 1998. The stomach is a source of leptin. Nature. 394: 790-793.
43. Smith-Kirwin, S. M., D. M. O'Connor, J. De Johnston, E. D. Lancey, S. G. Hassink, and V. L. Funanage. 1998. Leptin expression in human mammary epithelial cells and breast milk. J. Clin. Endocrinol. Metab. 83: 1810-1813.
44. Chen, H., O. Charlat, L. A. Tartaglia, E. A. Woolf, X. Weng, S. J. Ellis, N. D. Lakey, J. Culpepper, K.J. Moore, R. E. Breitbart, G. M. Duyk, R. I. Tepper, and J. P. Morgenstern. 1996. Evidence that the diabetes gene encodes the leptin receptor: identification of a mutation in the leptin receptor gene in db/db mice. Cell. 84: 491-495.
45. Chua, S. C., Jr., W. K. Chung, X. S. Wu-Peng, Y. Zhang, S. M. Liu, L. Tartaglia, and R. L. Leibel. 1996. Phenotypes of mouse diabetes and rat fatty due to mutations in the OB (leptin) receptor. Science. 271:994-996.
46. Yamashita, T., T. Murakami, S. Otani, M. Kuwajima, and K. Shima. 1998. Leptin receptor signal transduction: OBRa and OBRb of fa type. Biochem. Biophys. Res. Commun. 246: 752-759.
47. Lee, G. H., R. Proenca, J. M. Montez, K. M. Carroll, J. G. Darvishzadeh, J. I. Lee, and J. M. Friedman. 1996. Abnormal splicing of the leptin receptor in diabetic mice. Nature. 379:632-635.
48. Friedman, J. E., T. Ishizuka, S. Liu, C. J. Farrell, D. Bedol, R. J. Koletsky, H. L. Kaung, and P. Ernsberger. 1997. Reduced insulin receptor signaling in the obese spontaneously hypertensive Koletsky rat. Am. J. Physiol. 273: E1014-1023.
49. Phillips, M. S., Q. Liu, H. A. Hammond, V. Dugan, P. J. Hey, C. J. Caskey, and J. F. Hess. 1996. Leptin receptor missense mutation in the fatty Zucker rat. Nat. Genet. 13: 18-19.
50. Chua, S. C., Jr., D. W. White, X. S. Wu-Peng, S. M. Liu, N. Okada, E. E. Kershaw, W. K. Chung, L. Power-Kehoe, M. Chua, L. A. Tartaglia, and R. L. Leibel. 1996. Phenotype of fatty due to Gln269Pro mutation in the leptin receptor (Lepr). Diabetes. 45: 1141-1143.
51. Yamashita, T., T. Murakami, M. Iida, M. Kuwajima, and K. Shima. 1997. Leptin receptor of Zucker fatty rat performs reduced signal transduction. Diabetes. 46: 1077-1080.
52. da Silva, B. A., C. Bjorbaek, S. Uotani, and J. S. Flier. 1998. Functional properties of leptin receptor isoforms containing the gln→pro extracellular domain mutation of the fatty rat. Endocrinology. 139: 3681-3690.
53. Crouse, J. A., G. E. Elliott, T. L. Burgess, L. Chiu, L. Bennett, J. Moore, M. Nicolson, and R. E. Pacifici. 1998. Altered cell surface expression and signaling of leptin receptors containing the fatty mutation. J. Biol. Chem. 273: 18365-18373.
54. Cusin, I., F. Rohner-Jeanrenaud, A. Stricker-Krongrad, and B. Jeanrenaud. 1996. The weight-reducing effect of an intracerebroventricular bolus injection of leptin in genetically obese fa/fa rats. Reduced sensitivity compared with lean animals. Diabetes. 45:1446-1450.
55. al-Barazanji, K. A., R. E. Buckingham, J. R. Arch, A. Haynes, D. E. Mossakowska, D. L. McBay, S. D. Holmes, M. T. McHale, X. M. Wang, and I. S. Gloger. 1997. Effects of intracerebroventricular infusion of leptin in obese Zucker rats. Obes. Res. 5: 387-394.
56. Wu-Peng, X. S., S. C. Chua, Jr., N. Okada, S. M. Liu, M. Nicolson, and R. L. Leibel. 1997. Phenotype of the obese Koletsky (f) rat due to Tyr763Stop mutation in the extracellular domain of the leptin receptor (Lepr): evidence for deficient plasma-to-CSF transport of leptin in both the Zucker and Koletsky obese rat. Diabetes. 46:513-518.
57. Seeley, R. J., K. A. Yagaloff, S. L. Fisher, P. Burn, T. E. Thiele, G. van Dijk, D. G. Baskin, and M. W. Schwartz. 1997. Melanocortin receptors in leptin effects. Nature. 390: 349.
58. Erickson, J. C., G. Hollopeter, and R. D. Palmiter. 1996. Attenuation of the obesity syndrome of ob/ob mice by the loss of neuropeptide Y. Science. 274: 1704-1707.
59. Wang, N. D., M. J. Finegold, A. Bradley, C. N. Ou, S. V. Abdelsayed, M. D. Wilde, L. R. Taylor, D. R. Wilson, and G. J. Darlington. 1995. Impaired energy homeostasis in C/EBP alpha knockout mice. Science. 269: 1108-1112.
60. Tanaka, T., N. Yoshida, T. Kishimoto, and S. Akira. 1997. Defective adipocyte differentiation in mice lacking the C/EBPβ and/or C/EBPS gene. EMBO J. 16: 7432-7443.
61. Moitra, J., M. M. Mason, M. Olive, D. Krylov, O. Gavrilova, B. Marcussamuels, L. Feigenbaum, E. Lee, T. Aoyama, M. Eckhaus, M. L. Reitman, and C. Vinson. 1998. Life without fat: a transgenic mouse. Genes Dev. 12: 3168-3181.
62. Shimomura, I., R. E. Hammer, J. A. Richardson, S. Ikemoto, Y. Bashmakov, J. L. Goldstein, and M. S. Brown. 1998. Insulin resistance and diabetes mellitus in transgenic mice expressing nuclear SREBP-1c in adipose tissue - model for congenital generalized lipodystrophy. Genes Dev. 12: 3182-3194.
63. Montague, C. T., I. S. Farooqi, J. P. Whitehead, M. A. Soos, H. Rau, N. J. Wareham, C. P. Sewter, J. E. Digby, S. N. Mohammed, J. A. Hurst, C. H. Cheetham, A. R. Earley, A. H. Barnett, J. B. Prins, and S. O'Rahilly. 1997. Congenital leptin deficiency is associated with severe early-onset obesity in humans. Nature. 387: 903-908.
64. Strobel, A., T. Issad, L. Camoin, M. Ozata, and A. D. Strosberg. 1998. A leptin missense mutation associated with hypogonadism and morbid obesity. Nat. Genet. 18: 213-215.
65. Karvonen, M. K., U. Pesonen, P. Heinonen, M. Laakso, A. Rissanen, H. Naukkarinen, R. Valve, M. I. J. Uusitupa, and M. Koulu. 1998. Identification of new sequence variants in the leptin gene. J. Clin. Endocrinol. Metab. 83: 3239-3242.
66. Clement, K., C. Vaisse, N. Lahlou, S. Cabrol, V. Pelloux, D. Cassuto, M. Gourmelen, C. Dina, J. Chambaz, J. M. Lacorte, A. Basdevant, P. Bougneres, Y. Lebouc, P. Froguel, and B. Guy-Grand. 1998. A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction. Nature. 392: 398-401.
67. Jackson, R. S., J. W. M. Creemers, S. Ohagi, M. L. Raffin-Sanson, L. Sanders, C. T. Montague, J. C. Hutton, and S. O'Rahilly. 1997. Obesity and impaired prohormone processing associated with mutations in the human prohormone convertase 1 gene. Nat. Genet. 16: 303-306.
68. Benjannet, S., N. Rondeau, R. Day, M. Chretien, and N. G. Seidah. 1991. PC1 and PC2 are proprotein convertases capable of cleaving proopiomelanocortin at distinct pairs of basic residues. Proc. Natl. Acad. Sci. USA. 88: 3564-3568.
69. Krude, H., H. Biebermann, W. Luck, R. Horn, G. Brabant, and A. Gruters. 1998. Severe early-onset obesity, adrenal insufficiency and red hair pigmentation caused by POMC mutations in humans. Mat. Genet. 19: 155-157.
70. Joerg, H., H. R. Fries, E. Meijerink, and G. F. Stranzinger. 1996. Red coat color in Holstein cattle is associated with a deletion in the MSHR gene. Mamm. Genome. 7: 317-318.
71. Klungland, H., D. I. Vage, L. Gomez-Raya, S. Adalsteinsson, and S. Lien. 1995. The role of melanocyte-stimulating hormone (MSH) receptor in bovine coal color determination. Mamm. Genome. 6: 636-639.
72. Hu, E., J. B. Kim, P. Sarraf, and B. M. Spiegelman. 1996. Inhibition of adipogenesis through MAP kinase-mediated phosphorylation of PPARγ. Science. 274: 2100-2103.
73. Ristow, M., D. Mullerwieland, A. Pfeiffer, W. Krone, and C. R. Kahn. 1998. Obesity associated with a mutation in a genetic regulator of adipocyte differentiation. N. Engl. J. Med. 339: 953-959.
74. Vaisse, C., K. Clement, B. Guygrand, and P. Froguel. 1998. A frameshift mutation in human MC4R is associated with a dominant form of obesity. Nat. Genet. 20: 113-114.
75. Yeo, G. S. H., I. S. Farooqi, S. Aminian, D. J. Halsall, R. C. Stanhope, and S, O'Rahilly. 1998. A frameshift mutation in MC4R associated with dominantly inherited human obesity. Nat. Genet. 20: 111-112.
76. Hinney, A., A. Schmidt, K. Nottebom, O. Heibült, I. Becker, A. Ziegler, G. Gerber, M. Sina, T. Görg, H. Mayer, W. Siegfried, M. Fichter, H. Remschmidt, and J. Hebebrand. 1999. Several mutations in the melanocortin-4 receptor gene including a nonsense and a frameshift mutation associated with dominantly inherited obesity in humans. J. Clin. Endocrinol. Metab. 84: 1483-1486.
77. Shenker, A. 1995. G protein-coupled receptor structure and function: the impact of disease-causing mutations. Baillieres Clin. Endocrinol. Metab. 9: 427-451.
78. Chagnon, Y. C., L. Perusse, and C. Bouchard. 1998. The human obesity gene map: the 1997 update. Obes. Res. 6: 76-92.
79. Gunay-Aygun, M., S. B. Cassidy, and R. D. Nicholls. 1997. Prader-Willi and other syndromes associated with obesity and mental retardation. Behav. Genet. 27: 307-324.
80. Nicholls, R. D., S. Saitoh, and B. Horsthemke. 1998. Imprinting in Prader-Willi and Angelman syndromes. Trends Genet. 14: 194-200.
81. Woods, M. O., T. L. Young, P. S. Parfrey, D. Hefferton, J. S. Green, and W. S. Davidson. 1999. Genetic heterogeneity of Bardet-Biedl syndrome in a distinct Canadian population: evidence for a fifth locus. Genomics. 55: 2-9.
82. Garg, A., J. L. Fleckenstein, R. M. Peshock, and S. M. Grundy. 1992. Peculiar distribution of adipose tissue in patients with congenital generalized lipodystrophy. J. Clin. Endocrinol. Metab. 75: 358-361.
83. Chandalia, M., A. Garg, F. Vuitch, and F. Nizzi. 1995. Postmortem findings in congenital generalized lipodystrophy. J. Clin. Endocrinol. Metab. 80: 3077-3081.
84. Fleckenstein, J. L., A. Garg, F. J. Bonte, M. F. Vuitch, and R. M. Peshock. 1992. The skeleton in congenital generalized lipodystrophy: evaluation using whole-body radiographic surveys, magnetic resonance imaging and technetium-99m bone scintigraphy. Skeletal Radial. 21: 381-386.
85. Pardini, V. C., I. M. Victoria, S. M. Rocha, D. G. Andrade, A. M. Rocha, F. B. Pieroni, G. Milagres, S. Purisch, and G. Velho. 1998. Leptin levels, beta-cell function, and insulin sensitivity in families with congenital and acquired generalized lipoatropic diabetes. J. Clin. Endocrinol. Metab. 83: 503-508
86. Vigouroux, C., E. Khallouf, C. Bourut, J. J. Robert, M. de Kerdanet, N. Tubiana-Rufi, S. Faure, J. Weissenbach, J. Capeau, and J. Magre. 1997. Genetic exclusion of 14 candidate genes in lipoatropic diabetes using linkage analysis in 10 consanguineous families. J. Clin. Endocrinol. Metab. 82: 3438-3444.
87. Silver, K., J. Walston, L. Plotnick, S. I. Taylor, C. R. Kahn, and A. R. Shuldiner. 1997. Molecular scanning of beta-3-adrenergic receptor gene in total congenital lipoatrophic diabetes mellitus. J. Clin. Endocrinol. Metab. 82: 3395-3398.
88. Okazawa, H., H. Mori, Y. Tamori, S. Araki, T. Niki, J. Masugi, M. Kawanishi, T. Kubota, H. Shinoda, and M. Kasuga. 1997. No coding mutations are detected in the peroxisome proliferator-activated receptor-gamma gene in Japanese patients with lipoatrophic diabetes. Diabetes. 46: 1904-1906.
89. Vigouroux, C., L. Fajas, E. Khallouf, M. Meier, G. Gyapay, O. Lascols, J. Auwerx, J. Weissenbach, J. Capeau, and J. Magre. 1998. Human peroxisomc proliferator-activated receptor-gamma2: genetic mapping, identification of a variant in the coding sequence, and exclusion as the gene responsible for lipoatrophic diabetes. Diabetes. 47: 490-492.
90. Garg, A. 1999. The role of body fat distribution in insulin resistance. In: Insulin Resistance: the Metabolic Syndrome X. G. M. Reaven and A. A. Laws, editors. The Humana Press, Totowa, NJ. 83-96.
91. Dunnigan, M. G., M. A. Cochrane, A. Kelly, and J. W. Scott. 1974. Familial lipoatrophic diabetes with dominant transmission: a new syndrome. Q. J. Med. 49: 33-48.
92. Garg, A., R. M. Peshock, and J. L. Fleckenstein. 1999. Adipose tissue distribution pattern in patients with familial partial lipodystrophy (Dunnigan variety). J. Clin. Endocrinol. Metab. 84: 170-174.
93. Peters, J. M., R. Barnes, L. Bennett, W. M. Gitomer, A. M. Bowcock, and A. Garg. 1998. Localization of the gene for familial partial lipodystrophy (Dunnigan variety) to chromosome 1q21-22. Nat. Genet. 18: 292-295.
94. Jackson, S. N., J. Pinkney, A. Bargiotta, C. D. Veal, T. A. Howlett, P. G. McNally, R. Corral, A. Johnson, and R. C. Trembath. 1998. A defect in the regional deposition of adipose tissue (partial lipodystrophy) is encoded by a gene at chromosome 1q. Am. J. Hum. Genet. 63: 534-540.
95. Anderson, J. L., M. Khan, W. S. David, Z. Mahdavi, F. Q. Nuttall, E. Krech, S. G. West, J. M. Vance, M. A. Pericak-Vance, and M. A. Nance. 1999. Confirmation of linkage of hereditary partial lipodystrophy to chromosome 1q21-22. Am. J. Med. Genet. 82: 161-165.
96. Shutter, J. R., M. Graham, A. C. Kinsey, S. Scully, R. Luthy, and K. L. Stark. 1997. Hypothalamic expression of ART, a novel gene related to agouti, is up-regulated in obese and diabetic mutant mice. Genes Dev. 11: 593-602.
97. Zemel, M. B. 1998. Agouti/melanocortin interactions with leptin pathways in obesity. Nutr. Rev. 56: 271-274.
98. Kask, A., L. Rago, J. E. S. Wikberg, and H. B. Schioth. 1998. Evidence for involvement of the melanocortin MC4 receptor in the effects of leptin on food intake and body weight. Eur. J. Pharmacol. 360: 15-19.
99. Considine, R. V., M. K. Sinha, M. L. Heiman, A. Kriauciunas, T. W. Stephens, M. R. Nyce, J. P. Ohannesian, C. C. Marco, L. J. McKee, T. L. Bauer, and J. F. Caro. 1996. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N. Engl. J. Med. 334: 292-295.
100. Considine, R. V., E. L. Considine, C. J. Williams, M. R. Nyce, S. A. Magosin, T. L. Bauer, E. L. Rosato, J. Colberg, and J. F. Caro. 1995. Evidence against either a premature stop codon or the absence of obese gene mRNA in human obesity. J. Clin. Invest. 95: 2986-2988.
101. Maffei, M., M. Stoffel, M. Barone, B. Moon, M. Dammerman, E. Ravussin, C. Bogardus, D. S. Ludwig, J. S. Flier, M. Talley, S. Auerbach, and J. M. Friedman. 1996. Absence of mutations in the human OB gene in obese/diabetic subjects. Diabetes. 45: 679-682.
102. Clement, K., C. Garner, J. Hager, A. Philippi, C. LeDuc, A. Carey, T. J. Harris, C. Jury, L. R. Cardon, A. Basdevant, F. Demenais, B. Guy-Grand, M. North, and P. Froguel. 1996. Indication for linkage of the human OB gene region with extreme obesity. Diabetes. 45: 687-690.
103. Reed, D. R., Y. Ding, W. Xu, C. Gather, E. D. Green, and R. A. Price. 1996. Extreme obesity may be linked to markers flanking the human OB gene. Diabetes. 45: 691-694.
104. Roth, H., A. Hinney, A. Ziegler, N. Barth, G. Gerber, K. Stein, T. Bromel, H. Mayer, W. Siegfried, H. Schafer, H. Remschmidt, K. H. Grzeschik, and J. Hebebrand. 1997. Further support for linkage of extreme obesity to the obese gene in a study group of obese children and adolescents. Exp. Clin. Endocrinol. Diabetes. 105: 341-344.
105. Lapsys, N. M., S. M. Furler, K. R. Moore, T. V. Nguyen, H. Herzog, G. Howard, K. Samaras, D. G. Carey, N. A. Morrison, J. A. Eisman, and D. J. Chisholm. 1997. Relationship of a novel polymorphic marker near the human obese (OB) gene to fat mass in healthy women. Obes. Res. 5: 430-433.
106. Spiegelman, B. M., and J. S. Flier. 1996. Adipogenesis and obesity: rounding out the big picture. Cell. 87: 377-389.
107. Hinney, A., A. Bornscheuer, M. Depenbusch, B. Mierke, A. Tolle, K. Middeke, A. Ziegler, H. Roth, G. Gerber, K. Zamzow, A. Ballauff, A. Hamann, H. Mayer, W. Siegfried, G. Lehmkuhl, F. Poustka, M. H. Schmidt, H. Hermann, B. M. Herpertzdahlmann, M. Fichter, H. Remschmidt, and J. Hebebrand. 1998. No evidence for involvement of the leptin gene in anorexia nervosa, bulimia nervosa, underweight or early onset extreme obesity -identification of two novel mutations in the coding sequence and a novel polymorphism in the leptin gene linked upstream region. Mol. Psychiatry. 3: 539-543.
108. Coleman, D. L. 1979. Obesity genes: beneficial effects in heterozygous mice. Science. 203: 663-665.
109. Chagnon, Y. C., W. J. Chen, L. Perusse, M. Chagnon, A. Nadeau, W. O. Wilkison, and C. Bouchard. 1997. Linkage and association studies between the melanocortin receptors 4 and 5 genes and obesity-related phenotypes in the Quebec Family Study. Mol. Med. 3: 663-673.
110. Thompson, D. B., E. Ravussin, P. H. Bennett, and C. Bogardus. 1997. Structure and sequence variation at the human leptin receptor gene in lean and obese Pima Indians. Hum. Mol. Genet. 6: 675-679.
111. Comuzzie, A. G., J. E. Hixson, L. Almasy, B. D. Mitchell, M. C. Mahaney, T. D. Dyer, M. P. Stern, J. W. MacCluer, and J. Blangero. 1997. A major quantitative trait locus determining serum leptin levels and fat mass is located on human chromosome 2. Nat. Genet. 15: 273-276.
112. Hager, J., C. Dina, S. Francke, S. Dubois, M. Houari, V. Vatin, E. Vaillant, N. Lorentz, A. Basdevant, K. Clement, B. Guygrand, and P. Froguel. 1998. A genome-wide scan for human obesity genes reveals a major susceptibility locus on chromosome 10. Nat. Genet. 20: 304-308.
113. Shepherd, P. R., L. Gnudi, E. Tozzo, H. Yang, F. Leach, and B. B. Kahn. 1993. Adipose cell hyperplasia and enhanced glucose disposal in transgenic mice overexpressing GLUT4 selectively in adipose tissue. J. Biol. Chem. 268: 22243-22246.
114. Gnudi, L., E. Tozzo, P. R. Shepherd, J. L. Bliss, and B. B. Kahn. 1995. High level overexpression of glucose transporter-4 driven by an adipose-specific promoter is maintained in transgenic mice on a high fat diet, but does not prevent impaired glucose tolerance. Endocrinology. 136: 995-1002.
115. Levak-Frank, S., H. Radner, A. Walsh, R. Stollberger, G. Knipping, G. Hoefler, W. Sattler, P. H. Weinstock, J. L. Breslow, and R. Zechner. 1995. Muscle-specific overexpression of lipoprotein lipase causes a severe myopathy characterized by proliferation of mitochondria and peroxisomes in transgenic mice. J. Clin. Invest. 96:976-986.
116. Soloveva, V., R. A. Graves, M. M. Rasenick, B. M. Spiegelman, and S. R. Ross. 1997. Transgenic mice overexpressing the beta 1-adrenergic receptor in adipose tissue are resistant to obesity. Mol. Endocrinol. 11: 27-38.
117. Lowell, B. B., V. S. Susulic, A. Hamann, J. A. Lawitts, J. Himms-Hagen, B. B. Boyer, L. P. Kozak, and J. S. Flier. 1993. Development of obesity in transgenic mice after genetic ablation of brown adipose tissue. Nature. 366: 740-742.
118. Klaus, S., H. Munzberg, C. Truloff, and G. Heldmaier. 1998. Physiology of transgenic mice with brown fat ablation: obesity is due to lowered body temperature. Am. J. Physiol. 274: R287-293.
119. Kopecky, J., G. Clarke, S. Enerback, B. Spiegelman, and L. P. Kozak. 1995. Expression of the mitochondrial uncoupling protein gene from the aP2 gene promoter prevents genetic obesity. J. Clin Invest. 96: 2914-2923.
120. Pomp, D., A. M. Oberbauer, and J. D. Murray. 1996. Development of obesity following inactivalion of a growth hormone transgene in mice. Transgenic Res. 5: 13-23.
121. Oberbauer, A. M., J. S. Stern, P. R. Johnson, B. A. Horwitz, J. B. German, S. D. Phinney, D. H. Beermann, D. Pomp, and J. D. Murray. 1997. Body composition of inactivated growth hormone (oMtla-oGH) transgenic mice: generation of an obese phenotype. Growth Dev. Aging. 61: 169-179.
122. Kushi, A., H. Sasai, H. Koizumi, N. Takeda, M. Yokoyama, and M. Nakamura. 1998. Obesity and mild hyperinsulinemia found in neuropeptide Y-Y1 receptor-deficient mice. Proc. Natl. Acad. Sci. USA. 95: 15659-15664.
123. Susulic, V. S., R. C. Frederich, J. Lawitts, E. Tozzo, B. B. Kahn, M. E. Harper, J. Himms-Hagen, J. S. Flier, and B. B. Lowell. 1995. Targeted disruption of the beta 3-adrenergic receptor gene. J. Biol. Chem. 270: 29483-29492.
124. Katz, E. B., A. E. Stenbit, K. Hatton, R. DePinho, and M. J. Charron. 1995. Cardiac and adipose tissue abnormalities but not diabetes in mice deficient in GLUT4. Nature. 377: 151-155.
125. Dong, Z. M., J. C. Gutierrez-Ramos, A. Coxon, T. N. Mayadas, and D. D. Wagner. 1997. A new class of obesity genes encodes leukocyte adhesion receptors. Proc. Natl. Acad. Sci. USA. 94: 7526-7530.
126. Bunger, L., H. Wallace, J. O. Bishop, I. M. Hastings, and W. G. Hill. 1998. Effects of thyroid hormone deficiency on mice selected for increased and decreased body weight and fatness. Genet. Res. 72: 39-53.
127. Ohki-Hamazaki, H., K. Watase, K. Yamamoto, H. Ogura, M. Yamano, K. Yamada, H. Maeno, J. Imaki, S. Kikuyama, E. Wada, and K. Wada. 1997. Mice lacking bombesin receptor subtype-3 develop metabolic defects and obesity. Nature. 390: 165-169.
128. Cummings, D. E., E. P. Brandon, J. V. Planas, K. Motamed, R. L. Idzerda, and G. S. McKnight. 1996. Genetically lean mice result from targeted disruption of the RII beta subunit of protein kinase A. Nature. 382: 622-626.
129. Costet, P., C. Legendre, J. More, A. Edgar, P. Galtier, and T. Pineau. 1998. Peroxisome proliferator-activated receptor alpha-isoform deficiency leads to progressive dyslipidemia with sexually dimorphic obesity and steatosis. J. Biol. Chem. 273: 29577-29585.
130. Tecott, L. H., L. M. Sun, S. F. Akana, A. M. Strack, D. H. Lowenstein, M. F. Dallman, and D. Julius. 1995. Eating disorder and epilepsy in mice lacking 5-HT2c serotonin receptors. Nature. 374: 542-546.
131. Nonogaki, K., A. M. Strack, M. F. Dallman, and L. H. Tecott. 1998. Leptin-independent hyperphagia and type 2 diabetes in mice with a mutated serotonin 5-HT2C receptor gene. Nat. Med. 4: 1152-1156.
132. Garg, A., R. Wilson, R. Barnes, E. Arioglu, Z. Zaidi, F. Gurakan, N. Kocak, S. O'Rahilly, S. I. Taylor, S. B. Patel, and A. M. Bowcock. 1999. A gene for congenital generalized lipodystrophy maps to human chromosome 9q34. J. Clin. Endocrinol. Metab. 84: In press.